SEVELAMER for Hyperparathyroidism secondary: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where SEVELAMER was used for Hyperparathyroidism secondary.
Most Reported Side Effects for SEVELAMER
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Constipation | 2,041 | 35.7% | 1 | 32 |
| Pruritus | 772 | 13.5% | 0 | 10 |
| Diarrhoea | 665 | 11.6% | 8 | 31 |
| Nausea | 484 | 8.5% | 5 | 37 |
| Vomiting | 300 | 5.3% | 4 | 34 |
| Flatulence | 217 | 3.8% | 0 | 9 |
| Abdominal pain | 193 | 3.4% | 6 | 45 |
| Death | 170 | 3.0% | 167 | 13 |
| Crystal deposit intestine | 168 | 2.9% | 9 | 79 |
| Dyspepsia | 141 | 2.5% | 0 | 0 |
| Hyperphosphataemia | 129 | 2.3% | 1 | 10 |
| Colitis | 113 | 2.0% | 2 | 58 |
| Hospitalisation | 106 | 1.9% | 12 | 105 |
| Overdose | 101 | 1.8% | 3 | 3 |
| Drug ineffective | 85 | 1.5% | 6 | 21 |
Other Indications for SEVELAMER
Product used for unknown indication (2,966)
Hyperphosphataemia (533)
Chronic kidney disease (187)
End stage renal disease (176)
Blood phosphorus increased (47)
Blood phosphorus (25)
Blood phosphorus abnormal (25)
Dialysis (20)
Renal failure (18)
Renal failure chronic (18)
Other Drugs Used for Hyperparathyroidism secondary
CINACALCET (15,990)
PARICALCITOL (2,607)
ETELCALCETIDE (1,407)
CALCIFEDIOL (352)
SENSIPAR (248)
ZEMPLAR (61)
CALCITRIOL (50)
DOXERCALCIFEROL (34)
DENOSUMAB (22)
MIMPARA (22)